← Back to directory

Kamlesh Khunti

Researcher Next ID · RN-024800

Researcher · Medicine

University of Leicester

Leicester, United Kingdom

Not currently recruitingFunding unknown
Works count
2,085
Citation count
122,857
H-index
167
i10-index
1,097

Research interests

Medicine
Diabetes Treatment and Management
Diabetes, Cardiovascular Risks, and Lipoproteins
Diabetes Management and Research
Diabetes Management and Education
Chronic Disease Management Strategies

Publications

  • 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025

    Diabetes Care · 2024 · https://doi.org/10.2337/dc25-s002

  • Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK

    The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)00457-9

  • 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024

    Diabetes Care · 2023 · https://doi.org/10.2337/dc24-s002

  • 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

    European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad192

  • Current insights and emerging trends in early-onset type 2 diabetes

    The Lancet Diabetes & Endocrinology · 2023 · https://doi.org/10.1016/s2213-8587(23)00225-5

  • The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis

    EClinicalMedicine · 2022 · 10.1016/j.eclinm.2022.101762

  • Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    Diabetes Care · 2022 · https://doi.org/10.2337/dci22-0027

  • 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023

    Diabetes Care · 2022 · https://doi.org/10.2337/dc23-s002

  • Introduction and Methodology: Standards of Care in Diabetes—2023

    Diabetes Care · 2022 · https://doi.org/10.2337/dc23-sint

  • KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Kidney International · 2022 · 10.1016/j.kint.2022.06.008

  • 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

    Diabetes Care · 2022 · 10.2337/dc23-s009

  • Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

    BMJ · 2021 · 10.1136/bmj.n693

  • COVID-19 and metabolic disease: mechanisms and clinical management

    The Lancet Diabetes & Endocrinology · 2021 · https://doi.org/10.1016/s2213-8587(21)00244-8

  • Practical recommendations for the management of diabetes in patients with COVID-19

    The Lancet Diabetes & Endocrinology · 2020 · 10.1016/s2213-8587(20)30152-2

  • Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

    The Lancet Diabetes & Endocrinology · 2020 · 10.1016/s2213-8587(20)30272-2

  • Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

    The Lancet Diabetes & Endocrinology · 2020 · 10.1016/s2213-8587(20)30271-0

  • New-Onset Diabetes in Covid-19

    New England Journal of Medicine · 2020 · 10.1056/nejmc2018688

  • Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis

    BMJ · 2020 · 10.1136/bmj.m1361

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz486

  • Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

    Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2018.03.009

  • Type 2 diabetes

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30058-2

  • Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

    Circulation · 2017 · 10.1161/circulationaha.117.029190

  • Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1600176

  • Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1600175

  • Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

    Diabetes Care · 2014 · https://doi.org/10.2337/dc14-0920

  • Real‐world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review

    Diabetic Medicine · 2013 · https://doi.org/10.1111/dme.12128

  • Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care

    BMJ · 2012 · https://doi.org/10.1136/bmj.e2333

  • Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis

    Diabetologia · 2012 · https://doi.org/10.1007/s00125-012-2677-z

  • The association between depression and health‐related quality of life in people with type 2 diabetes: a systematic literature review

    Diabetes/Metabolism Research and Reviews · 2010 · https://doi.org/10.1002/dmrr.1065

  • Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis

    BMJ · 2010 · https://doi.org/10.1136/bmj.c4093

  • Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database

    BMJ · 2009 · https://doi.org/10.1136/bmj.b4731

  • Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial

    BMJ · 2008 · 10.1136/bmj.39474.922025.be

  • Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

    BMJ · 2007 · 10.1136/bmj.39063.689375.55

  • The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis

    Diabetic Medicine · 2006 · 10.1111/j.1464-5491.2006.01943.x

  • Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): Process modelling of pilot study

    Patient Education and Counseling · 2006 · https://doi.org/10.1016/j.pec.2006.04.007

Current projects

    No projects listed.